State Street’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$353K Hold
145,850
﹤0.01% 3738
2025
Q4
$636K Buy
145,850
+27,200
+23% +$147K ﹤0.01% 3624
2025
Q3
$498K Buy
118,650
+18,700
+19% +$66.4K ﹤0.01% 3666
2025
Q2
$287K Hold
99,950
﹤0.01% 3742
2025
Q1
$270K Buy
99,950
+8,300
+9% +$31.1K ﹤0.01% 3755
2024
Q4
$216K Buy
91,650
+22,000
+32% +$58.5K ﹤0.01% 3836
2024
Q3
$165K Hold
69,650
﹤0.01% 3866
2024
Q2
$136K Sell
69,650
-325,365
-82% -$1.11M ﹤0.01% 3923
2024
Q1
$2.54M Buy
395,015
+17,572
+5% +$160K ﹤0.01% 3204
2023
Q4
$5.29M Buy
377,443
+146,378
+63% +$2.31M ﹤0.01% 2915
2023
Q3
$5.66M Buy
231,065
+185,400
+406% +$4.7M ﹤0.01% 2861
2023
Q2
$1.49M Buy
45,665
+37,965
+493% +$1.07M ﹤0.01% 3501
2023
Q1
$214K Buy
+7,700
New +$125K ﹤0.01% 4058

Other funds holding GNLX

State Street's GNLX Position: Q1 2026 in Review

State Street held its Genelux (GNLX) position steady in Q1 2026 at 145,850 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

State Street first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.66M in Q3 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • State Street held 145,850 shares of Genelux worth $353K as of Q1 2026.
  • State Street left its Genelux share count unchanged in Q1 2026.
  • Genelux made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3738 holding.
  • State Street first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
  • State Street's Genelux position peaked at $5.66M in Q3 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.